Citation Impact
Citing Papers
Effect of the αGal Epitope on the Response to Small Intestinal Submucosa Extracellular Matrix in a Nonhuman Primate Model
2009
Cyclosporine Microemulsion and Tacrolimus are Associated with Decreased Chronic Allograft Failure and Improved Long-term Graft Survival as Compared with Sandimmune
2002
Towards the creation of decellularized organ constructs using irreversible electroporation and active mechanical perfusion
2010
Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial
2004
Acute rejection and late renal transplant failure: Risk factors and prognosis
2004
Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation
2011
Withdrawal of Cyclosporine or Prednisone Six Months after Kidney Transplantation in Patients on Triple Drug Therapy
2002
A Multicenter, Randomized, Double-Blind Trial of EverolimusVersusAzathioprine and Placebo to Maintain Steroid-Induced Remission in Patients With Moderate-to-Severe Active Crohn's Disease
2008
Acute kidney injury
2012 Standout
Laparoscopic live donor nephrectomy: The pediatric recipient in a dual‐site program
2007
Renal Transplantation From Non–Heart-Beating Donors: A Single-Center 10-Year Experience
2005
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
2008 Standout
DISCORDANT ORGAN XENOTRANSPLANTATION IN PRIMATES
1998
Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy
2004
A Nonsimultaneous, Extended, Altruistic-Donor Chain
2009 StandoutNobel
Vascularized and functional human liver from an iPSC-derived organ bud transplant
2013 StandoutNature
Everolimus Therapeutic Concentration Range Defined from a Prospective Trial with Reduced-Exposure Cyclosporine in De Novo Kidney Transplantation
2004
The Role of Therapeutic Drug Monitoring in Individualizing Immunosuppressive Drug Therapy: Recent Developments
2006
Scientific basis of organ preservation
2008
Target of Rapamycin Inhibitors (Sirolimus and Everolimus) for Primary Immunosuppression of Kidney Transplant Recipients: A Systematic Review and Meta-Analysis of Randomized Trials
2006
Carbon Monoxide Promotes Fas/CD95-induced Apoptosis in Jurkat Cells
2004
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Crohn's disease
2012 Standout
A PILOT STUDY OF STEROID-FREE IMMUNOSUPPRESSION IN THE PREVENTION OF ACUTE REJECTION IN RENAL ALLOGRAFT RECIPIENTS
2001
Heme oxygenase-1: unleashing the protective properties of heme
2003
Gene transfer of virally encoded chemokine antagonists vMIP-II and MC148 prolongs cardiac allograft survival and inhibits donor-specific immunity
2000
Hepatocellular carcinoma
2012 Standout
Growing pains: Non‐adherence with the immunosuppressive regimen in adolescent transplant recipients
2005
Human Biliverdin Reductase Is Autophosphorylated, and Phosphorylation Is Required for Bilirubin Formation
2001
Systemic sclerosis
2017 Standout
Identification of medication non‐adherence factors in adolescent transplant patients: The patient's viewpoint
2007
A Randomized Trial of Three Renal Transplant Induction Antibodies: Early Comparison of Tacrolimus, Mycophenolate Mofetil, and Steroid Dosing, and Newer Immune-Monitoring1
2005
Expression of -gal epitopes on HeLa cells transduced with adenovirus containing 1,3galactosyltransferase cDNA
2002
An overview of tissue and whole organ decellularization processes
2011 Standout
In vivo targeting of vaccinating tumor cells to antigen-presenting cells by a gene therapy method with adenovirus containing the α1,3galactosyltransferase gene
2005
Perspectives in Organ Preservation
2007
Expression of α-gal epitopes on ovarian carcinoma membranes to be used as a novel autologous tumor vaccine
2003
Xenotransplantation: Public Health Risks¡ªPatient vs. Society in an Emerging Field
2003
Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association
2022 Standout
Workshop on Late Renal Allograft Dysfunction
2005
Glycans in cancer and inflammation — potential for therapeutics and diagnostics
2005 StandoutNobel
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Gene regulation of heme oxygenase-1 as a therapeutic target
2000
Hepatocellular Carcinoma Patients Are Advantaged in the Current Liver Transplant Allocation System
2010
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Enteric Coated Mycophenolate Sodium is Therapeutically Equivalent to Mycophenolate Mofetil in de novoRenal Transplant Patients
2004
Immune responsiveness in renal transplant recipients: Mycophenolic acid severely depresses humoral immunity in vivo
2002
Xanthine oxidoreductase is central to the evolution and function of the innate immune system
2003 StandoutNobel
Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence-based analysis of 15 years of experience
2011
Non-heart beating organ donation: overview and future perspectives
2007
Remodelling the extracellular matrix in development and disease
2014 Standout
The Galα1,3Galβ1,4GlcNAc-R (α-Gal) epitope: A carbohydrate of unique evolution and clinical relevance
2007
Kidney Transplantation Using Elderly Non-Heart-Beating Donors: A Single-Center Experience
2006
Living unrelated renal transplantation: A good match for the pediatric candidate?
2013
Prevention of Venous Thromboembolism
2004 Standout
Therapeutic Drug Monitoring of Mycophenolate Mofetil in Transplantation
2006
Protective effect of carbon monoxide in transplantation
2006
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
2007 Standout
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Enteric-Coated Mycophenolate Sodium can be Safely Administered in Maintenance Renal Transplant Patients: Results of a 1-Year Study
2004
Mycophenolate mofetil in diffuse cutaneous systemic sclerosis--a retrospective analysis
2006
Autologous tumor vaccines processed to express ?-gal epitopes: a practical approach to immunotherapy in cancer
2004
Carbon Monoxide Induces Cytoprotection in Rat Orthotopic Lung Transplantation via Anti-Inflammatory and Anti-Apoptotic Effects
2003
Hodgkin's lymphoma after post‐transplant lymphoproliferative disease in a renal transplant recipient
2004
Machine Perfusion or Cold Storage in Deceased-Donor Kidney Transplantation
2008 Standout
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease
2018
Medication Noncompliance and its Implications in Transplant Recipients
2007
Post-Transplant Infections Now Exceed Acute Rejection as Cause for Hospitalization: A Report of the NAPRTCS
2004
Clinical Trials of Transplant Tolerance: Slow But Steady Progress
2003
Influence of Immunosuppressive Regimens on Graft Survival and Secondary Outcomes After Kidney Transplantation
2009
Hepatitis E Virus and Chronic Hepatitis in Organ-Transplant Recipients
2008 Standout
Does Donation After Cardiac Death Utilization Adversely Affect Hepatocellular Cancer Survival?
2016
A Literature Synthesis of Health Promotion Research in Salons and Barbershops
2014
Mycophenolate Mofetil Decreases Acute Rejection and may Improve Graft Survival in Renal Transplant Recipients When Compared with Azathioprine: A Systematic Review
2009
Short-term combination of mycophenolate mofetil with cyclosporine as a therapeutic option for renal transplant recipients
2002
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies
2001
Maintenance immunosuppression in the renal transplant recipient: An overview
2001
Long‐Term Use of Mycophenolate Mofetil is Associated With a Reduction in the Incidence and Risk of Late Rejection
2003
Organ Donation and Utilization in the United States, 1996–2005
2007
Binding of complement component Clq to myelin oligodendrocyte glycoprotein: A novel mechanism for regulating CNS inflammation
1997
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Hepatocellular Carcinoma
2011 Standout
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Thrombin Inhibition During Kidney Ischemia-Reperfusion Reduces Chronic Graft Inflammation and Tubular Atrophy
2010
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
2008 Standout
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Organ donation and transplantation trends in the United States, 2001
2003
Psychosocial Health of Living Kidney Donors: A Systematic Review
2006
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
2006 Standout
Recurrence of Hepatocellular Cancer After Resection
2014
Supporting the Health Care Transition From Adolescence to Adulthood in the Medical Home
2018
Impact of renal transplantation on survival in end-stage renal disease patients with elevated body mass index
2003
Treatment of HCV Infection by Targeting MicroRNA
2013 Standout
Liver Transplantation in the United States, 1999-2008
2010
Immune response to biologic scaffold materials
2008
Food-Related Illness and Death in the United States
1999 Standout
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Meta-analysis of the Complications of Laparoscopic Renal Surgery: Comparison of Procedures and Techniques
2006
"First, do no harm": monitoring outcomes during the transition from open to laparoscopic live donor nephrectomy in a Canadian centre.
2008
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients
2006
Morbidity and Mortality After Living Kidney Donation, 1999-2001: Survey of United States Transplant Centers
2003
Living Kidney Donor Decision Making and Communication
2011
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
2001 Standout
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Characteristics of protein–carbohydrate interactions as a basis for developing novel carbohydrate‐based antirejection therapies
2005
Risk of End-Stage Renal Disease Following Live Kidney Donation
2014 Standout
Fulminant hepatic failure: Summary of a workshop
1995
Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature
2019 StandoutNobel
Part 8: Post–Cardiac Arrest Care
2015 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Production of α-1,3-Galactosyltransferase Knockout Pigs by Nuclear Transfer Cloning
2002 StandoutScience
Metal–Organic Frameworks in Biomedicine
2011 Standout
Preformed and elicited antibodies to pig antigens in nonhuman primates and humans
2001
Global cancer statistics, 2012
2015 Standout
A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation
2013
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management
2012 Standout
The α‐gal epitope and the anti‐Gal antibody in xenotransplantation and in cancer immunotherapy
2005
Works of John C. Magee being referenced
Pediatric Transplantation in the United States, 1997–2006
2008
RANDOMIZED CONTROLLED TRIAL OF HAND-ASSISTED LAPAROSCOPIC VERSUS OPEN SURGICAL LIVE DONOR NEPHRECTOMY1
2001
Hepatopulmonary syndrome: Use of extracorporeal life support for life-threatening hypoxia following liver transplantation
2008
INTERACTION OF MYCOPHENOLATE MOFETIL AND HLA MATCHING ON RENAL ALLOGRAFT SURVIVAL
2001
Everolimus with Optimized Cyclosporine Dosing in Renal Transplant Recipients: 6-Month Safety and Efficacy Results of Two Randomized Studies
2004
COMPLEMENT ACTIVATION BY THE HYDROXYL RADICAL DURING INTESTINAL REPERFUSION
1994
Outcomes of pediatric living donor renal transplant after laparoscopic versus open donor nephrectomy
2002
Renal transplantations performed using non???heart-beating organ donors: going back to the future?1
2002
GENDER IMBALANCE IN LIVING DONOR RENAL TRANSPLANTATION1
2002
Early Pancreas Transplant Outcomes with Histidine-Tryptophan-Ketoglutarate Preservation: A Multicenter Study
2006
An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data
2009
Quality Improvement Targeting Adherence During the Transition from a Pediatric to Adult Liver Transplant Clinic
2015
Pediatric transplantation
2003
GENE TRANSFER OF IMMUNOMODULATORY PEPTIDES CORRELATES WITH HEME OXYGENASE-1 INDUCTION AND ENHANCED ALLOGRAFT SURVIVAL 1
2000
12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients
2006
Hand-assisted laparoscopic donor nephrectomy: comparable donor/recipient outcomes, costs, and decreased convalescence as compared to open donor nephrectomy
2001
THE IMPACT OF SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION ON LONG-TERM PATIENT SURVIVAL1
2001
Liver and Intestine Transplantation in the United States 1998–2007
2009
Limitations of EBV–PCR monitoring to detect EBV associated post‐transplant lymphoproliferative disorder
2003
MYCOPHENOLATE MOFETIL REDUCES LATE RENAL ALLOGRAFT LOSS INDEPENDENT OF ACUTE REJECTION
2000
Pediatric Transplantation in the United States,1995–2004
2006
Repeat Organ Transplantation in the United States, 1996–2005
2007
AFRICAN-AMERICAN RENAL TRANSPLANT RECIPIENTS EXPERIENCE DECREASED RISK OF DEATH DUE TO INFECTION: POSSIBLE IMPLICATIONS FOR IMMUNOSUPPRESSIVE STRATEGIES
2000
Pediatric transplantation
2004
MECHANISMS OF INJURY IN PORCINE LIVERS PERFUSED WITH BLOOD OF PATIENTS WITH FULMINANT HEPATIC FAILURE
1994
Randomized trial using hair stylists as lay health advisors to increase donation in African Americans.
2010
VARIATION IN THE LEVEL OF XENOANTIGEN EXPRESSION IN PORCINE ORGANS
1995
MECHANISMS OF INJURY IN PORCINE LIVERS PERFUSED WITH BLOOD OF PATIENTS WITH FULMINANT HEPATIC FAILURE
1994
Cardiac xenografts between primate species provide evidence for the importance of the alpha-galactosyl determinant in hyperacute rejection.
1995
Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation.
1995
12 MONTH CLINICAL TRIAL RESULTS OF SAFETY AND EFFICACY OF TROUGH-CONTROLLED CERTICAN® DOSING WITH REDUCED NEORAL® EXPOSURE IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS
2004
Treatment of Hepatic Failure with ex Vivo Pig-Liver Perfusion Followed by Liver Transplantation
1994